Latest News
In this video, Ira Epstein discusses the significant announcement of a ceasefire between Iran and Israel. He highlights the potential implications for peace and the challenges ahead, including unresolved issues such as enriched uranium.
Via Talk Markets · June 23, 2025
On Stocktwits, 24-hour message volume around HIMS soared 6,717% — the fifth highest among healthcare stocks. It was the top trending ticker on the platform late Monday.
Via Stocktwits · June 23, 2025
DefenCath, CorMedix’s lead product, was launched in hospitals in April 2024 and in outpatient settings in July 2024 following FDA approval.
Via Stocktwits · June 23, 2025
The e-commerce giant previously invested $16 billion in the country in 2023.
Via Stocktwits · June 23, 2025
The euro initially gapped lower against the US dollar, only to turn around and show signs of strength again as the world behaves as if it is not going to be overly concerned about the American strengths on Iran.
Via Talk Markets · June 23, 2025
Via Talk Markets · June 23, 2025
On Monday, Cathie Wood-led Ark Invest made significant trades involving Circle Internet Group Inc. (NYSE:CRCL), Robinhood Markets Inc. (NASDAQ:HOOD), Advanced Micro Devices Inc. (NASDAQ:<
Via Benzinga · June 23, 2025
The analyst noted that early tests of the partnership delivered impressive results, adding that the improved identity and cross-device targeting has helped brands achieve three times more value from their ad spend without increasing their budgets.
Via Stocktwits · June 23, 2025
Leading cryptocurrencies rallied Monday after President Donald Trump said Israel and Iran have agreed to a ceasefire to halt ongoing hostilities.
Via Benzinga · June 23, 2025
Amidst the geopolitical backdrop that seems to be worsening by the day, investors could find some stability in dividend stocks as they are historically viewed as a remarkable hedge against volatility. Here are the top three income-producing stocks
Via Talk Markets · June 23, 2025
The merger brings together two biotech firms aiming to tackle immune resistance in cancer, with plans to advance programs targeting Merkel Cell Carcinoma.
Via Stocktwits · June 23, 2025
Rezpegaldesleukin is being studied not only in atopic dermatitis but also in alopecia areata, with topline data from the second trial expected in December.
Via Stocktwits · June 23, 2025
Via The Motley Fool · June 23, 2025
Japan’s auto exports remain the biggest obstacle in reaching a trade deal with the U.S., according to opposition leaders briefed by Prime Minister Shigeru Ishiba.
Via Talk Markets · June 23, 2025
Kevin O'Leary once told a young founder to choose his $5 million startup over his fiancée, highlighting the harsh personal sacrifices entrepreneurship demands—an idea echoed by Mark Cuban and Barack Obama, who also believe success often comes at the cost of work-life balance.
Via Benzinga · June 23, 2025
Via The Motley Fool · June 23, 2025
Via The Motley Fool · June 23, 2025
Via The Motley Fool · June 23, 2025
Via The Motley Fool · June 23, 2025
Via Stocktwits · June 23, 2025
With thousands of units under management, the company has strategically positioned itself to capitalize on market demand while maintaining a strong emphasis on quality and customer satisfaction.
Via Talk Markets · June 23, 2025
Via Benzinga · June 23, 2025
Via Stocktwits · June 23, 2025
Quantum computing has been a red-hot sector until just recently. To my way of thinking, this is just a hot potato, and everyone is passing it around, hoping not to be the one who gets burned.
Via Talk Markets · June 23, 2025